A carregar...
Personalized therapy for lung cancer: striking a moving target
Molecular targeted therapy heralded a new era for the treatment of patients with oncogene-driven advanced-stage non–small-cell lung cancer (NSCLC). Molecular testing at the time of diagnosis guides therapy selection, and targeted therapies in patients with activating mutations in EGFR, BRAF, and rea...
Na minha lista:
| Publicado no: | JCI Insight |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6129126/ https://ncbi.nlm.nih.gov/pubmed/30089719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.120858 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|